Home NDC 0069-0336 Revatio
Product NDC 0069-0336
11-digit product format 000690336
Labeler code 0069
Product ID 0069-0336_eeeb2d77-bc88-45e8-afb2-f18cc8aa941e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sildenafil citrate
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler Pfizer Laboratories Div Pfizer Inc
Application NDA203109
Marketing category NDA
Marketing start 2014-06-02
Marketing end 0000-00-00
Substance SILDENAFIL CITRATE
Active strength 10 mg/mL
Pharmacologic classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203109-001 REVATIO SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL RLD 2012-08-30
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N203109-001 M-287 2026-01-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL RLD 2012-08-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2012-08-30 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0069-0336-21 Revatio 1 in 1 CARTON POWDER, FOR SUSPENSION 1 45 0069-0336-21 Revatio 112 mL in 1 BOTTLE POWDER, FOR SUSPENSION 112 45
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded SILDENAFIL CITRATE ACTIVE INGREDIENT BW9B0ZE037 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 SILDENAFIL ACTIVE MOIETY 3M7OB98Y7H REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 ANHYDROUS CITRIC ACID INACTIVE INGREDIENT XF417D3PSL REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 SORBITOL INACTIVE INGREDIENT 506T60A25R REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 SUCRALOSE INACTIVE INGREDIENT 96K6UQ3ZD4 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 TRISODIUM CITRATE DIHYDRATE INACTIVE INGREDIENT B22547B95K REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 WATER INACTIVE INGREDIENT 059QF0KO0R REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 33
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0069-0336 REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] 44 Legacy NDC, 2 package rows 20250410_f158fe10-d5dc-4432-b2c9-fc665401291b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0069-0336-21 00069033621 1 BOTTLE in 1 CARTON (0069-0336-21) > 112 mL in 1 BOTTLE 1 bottle 2014-06-02 0000-00-00 No No Current